<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) has long been recognized as a disorder with both myelodysplastic and myeloproliferative characteristics, some patients showing clinical and morphological features resembling <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) especially <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) with <z:mp ids='MP_0000220'>monocytosis</z:mp>, and others <z:hpo ids='HP_0001974'>leukocytosis</z:hpo> with <z:mp ids='MP_0000219'>neutrophilia</z:mp>, <z:mp ids='MP_0000220'>monocytosis</z:mp> and <z:hpo ids='HP_0001744'>splenomegaly</z:hpo> resembling myeloproliferative syndrome (MPS) </plain></SENT>
<SENT sid="1" pm="."><plain>The intrinsec differences determined at first the separation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> in two forms, one named "dysplastic", more similar with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>, and the other "proliferative", closer to <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> and then included by the recent WHO classification into a separate new created group--myelodysplastic diseases (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDD</z:e>)/<z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_512'>myeloproliferative diseases</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was the analysis of some features of 20 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>, with emphasis on the differences between the two forms </plain></SENT>
<SENT sid="3" pm="."><plain>The proliferative form of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> differed from the dysplastic one by greater white blood cells and neutrophils counts (P &lt; 0.001), a more important <z:mp ids='MP_0000220'>monocytosis</z:mp> in periferal blood (P = 0.07), and by the size and frequency of <z:hpo ids='HP_0001744'>splenomegaly</z:hpo> (P = 0.03) </plain></SENT>
<SENT sid="4" pm="."><plain>The sex and age of the patients, the frequency of the general symptoms, the frequency of the general symptoms and signs and that of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>, the <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> and hematocrit values, the platelet counts, the percentage of myeloblasts and monocytes in bone marrow, the frequency of dysplastic traits, the percentage of reticulocytes and the modified Bournemouth prognostic index were not significantly different </plain></SENT>
<SENT sid="5" pm="."><plain>These findings support the concept that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> is a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> "overlap" syndrome between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e> </plain></SENT>
</text></document>